NuMe Among Firms With Gut Feeling About Burgeoning Prebiotics Space
This article was originally published in The Pink Sheet Daily
Executive Summary
Prebiotics could grow from a currently "nonexistent" market to surpass the flourishing probiotics category in both revenues and supporting science, the prebiotics firm CEO says.
You may also be interested in...
New Products In Brief
Arbonne launches diversified supplements
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.